CAS Key Laboratory of Innate Immunity and Chronic Disease, USTC
中国科技大学生命科学学院中国科学院天然免疫与慢性疾病重点实验室
China
1 October 2019 - 30 September 2020
Principal institution: School of Life Sciences, USTC
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for CAS Key Laboratory of Innate Immunity and Chronic Disease, USTC published between 1 October 2019 - 30 September 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 22 | 4.33 |
Outputs by subject (Share)
| Subject | Count | Share | |
|---|---|---|---|
| Life Sciences | 18 | 3.24 | |
| Physical Sciences | 3 | 1.02 | |
| ACS Nano | 2 | 0.58 | |
|
Self-Reporting and Splitting Nanopomegranates Potentiate Deep Tissue Cancer Radiotherapy via Elevated Diffusion and Transcytosis
2020-07-07
|
0.33 | ||
|
Near-Infrared II Phototherapy Induces Deep Tissue Immunogenic Cell Death and Potentiates Cancer Immunotherapy
2019-10-22
|
0.25 | ||
| Nano Letters | 1 | 0.44 | |
| Chemistry | 2 | 0.51 | |
Top articles by Altmetric score in current window
Effective treatment of severe COVID-19 patients with tocilizumab.
Proceedings of the National Academy of Sciences of the United States of America
2020-04-29
Commensal viruses maintain intestinal intraepithelial lymphocytes via noncanonical RIG-I signaling
Nature Immunology
2019-10-21
Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance
Nature Immunology
2019-10-21
Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm
Nature Communications
2020-08-06
Myeloid PTEN promotes chemotherapy-induced NLRP3-inflammasome activation and antitumour immunity
Nature Cell Biology
2020-05-04
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
